Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of two speech and language approaches on speech problems in people with Parkinson's disease: the PD COMM RCT.
Sackley CM, Rick C, Brady MC, Burton C, Jowett S, Patel S, Woolley R, Masterson-Algar P, Nicoll A, Smith CH, Abdali Z, Ives N, Beaton G, Dickson S, Ottridge R, Nankervis H, Clarke CE; PD COMM Collaborative Group. Sackley CM, et al. Among authors: clarke ce. Health Technol Assess. 2024 Oct;28(58):1-141. doi: 10.3310/ADWP8001. Health Technol Assess. 2024. PMID: 39364774 Free PMC article. Clinical Trial.
Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB).
Clarke CE, Patel S, Ives N, Rick CE, Woolley R, Wheatley K, Walker MF, Zhu S, Kandiyali R, Yao G, Sackley CM. Clarke CE, et al. Health Technol Assess. 2016 Aug;20(63):1-96. doi: 10.3310/hta20630. Health Technol Assess. 2016. PMID: 27580669 Free PMC article. Clinical Trial.
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).
Sackley CM, Smith CH, Rick CE, Brady MC, Ives N, Patel S, Woolley R, Dowling F, Patel R, Roberts H, Jowett S, Wheatley K, Kelly D, Sands G, Clarke CE; PD COMM Pilot Collaborative Group. Sackley CM, et al. Among authors: clarke ce. Pilot Feasibility Stud. 2018 Jan 10;4:30. doi: 10.1186/s40814-017-0222-z. eCollection 2018. Pilot Feasibility Stud. 2018. PMID: 29344405 Free PMC article.
Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.
Smith CH, Patel S, Woolley RL, Brady MC, Rick CE, Halfpenny R, Rontiris A, Knox-Smith L, Dowling F, Clarke CE, Au P, Ives N, Wheatley K, Sackley CM. Smith CH, et al. Among authors: clarke ce. Clin Linguist Phon. 2019;33(10-11):1063-1070. doi: 10.1080/02699206.2019.1604806. Epub 2019 Apr 29. Clin Linguist Phon. 2019. PMID: 31035809
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial.
Scobie S, Jowett S, Lambe T, Patel S, Woolley R, Ives N, Rick C, Smith C, Brady MC, Clarke C, Sackley C. Scobie S, et al. Pilot Feasibility Stud. 2021 Aug 9;7(1):154. doi: 10.1186/s40814-021-00888-y. Pilot Feasibility Stud. 2021. PMID: 34372913 Free PMC article.
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.
Sackley CM, Rick C, Brady MC, Woolley R, Burton C, Patel S, Masterson-Algar P, Nicoll A, Smith CH, Jowett S, Ives N, Beaton G, Dickson S, Ottridge R, Sharp L, Nankervis H, Clarke CE; PD COMM collaborative group. Sackley CM, et al. Among authors: clarke ce. BMJ. 2024 Jul 10;386:e078341. doi: 10.1136/bmj-2023-078341. BMJ. 2024. PMID: 38986549 Free PMC article. Clinical Trial.
227 results